ZLD zelira therapeutics limited
Add to My Watchlist 0.00% ! 42.0¢

Yes Oludare needs to go this “ann” is actually quite good look...

  1. Mcdunk
    2,574 Posts.
    lightbulb Created with Sketch. 482
    clock Created with Sketch.
    10/01/22
    11:20
    Post #: 58747078
    Yes Oludare needs to go this “ann” is actually quite good look at bigger picture people Zld will be one of the only companies with validated formulations clinically backed and proven yeah its taking time but like l keep saying sit back relax and wait
    ZLD Price at posting: 3.3¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Drilling Commences at Leinster South Project in WA
right-arrow Created with Sketch.
NEWS Austral Resources to Acquire Rocklands to Transform North-West Queensland Copper
right-arrow Created with Sketch.
NEWS MTM Successful Uplisting Commences Trading on OTCQX Market in US
right-arrow Created with Sketch.
NEWS Paris Gold Project Drilling Underway Testing High-Grade Zones
right-arrow Created with Sketch.
NEWS More Outstanding Gallium Assay Results for Nimy at Block 3
right-arrow Created with Sketch.
NEWS R&D Tax Refund of $5.8M Received by Imugene to Support Clinical Development
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
42.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $4.996M
Open High Low Value Volume
42.0¢ 42.0¢ 42.0¢ $666 1.586K

Buyers (Bids)

No. Vol. Price($)
2 1415 42.0¢
 

Sellers (Offers)

Price($) Vol. No.
44.0¢ 1675 1
View Market Depth
Last trade - 15.20pm 07/07/2025 (20 minute delay) ?
ZLD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.